Patients who suffer from seasonal allergic rhinitis will be able to try SUBLINGUAL Oralair (ORR-ah-lair)

February 2013

Patients who suffer from seasonal allergic rhinitis will be able to try SUBLINGUAL Oralair (ORR-ah-lair) this year.

It will be used for patients between 5 and 50 years old who've had allergies for at least two pollen seasons...when other allergy meds aren't working or cause too many side effects.

Oralair contains extracts of five different grass pollens. It works by desensitizing the immune system to these grass pollen allergens.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get quote

Anticoagulants approval of Eliquis (apixaban) to prevent stroke in A fib will intensify the marketing war among the NEW oral anticoagulants
Influenza An earlier and more severe influenza season will bring more questions about how to prevent and treat flu
HIV AIDS Stribild (STRY-bild), a new combo for HIV
Diabetes LESS aggressive BP goals in some diabetes patients
Dyslipidemia Niacin will continue to fall out of favour for dyslipidemia
Cardiology Fewer patients will get digoxin for atrial fibrillation
Women s Health Some women will now use tamoxifen for up to 10 years instead of 5 years
Cannabinoids Health Canada will change how patients access medical marijuana
Respiratory Allergy Patients who suffer from seasonal allergic rhinitis will be able to try SUBLINGUAL Oralair (ORR-ah-lair)
Menopause alternatives to treat menopausal symptoms
Insomnia Sublinox (zolpidem) 5 mg tablets will be hitting your pharmacy shelves along with new dosing changes

Patients who suffer from seasonal allergic rhinitis will be able to try SUBLINGUAL Oralair (ORR-ah-lair)

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents